Back to top
more

Endo International plc (ENDP)

(Delayed Data from NSDQ)

$8.20 USD

8.20
3,004,238

+0.48 (6.22%)

Updated May 3, 2019 04:00 PM ET

After-Market: $8.19 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[ENDP]

Reports for Purchase

Showing records 281 - 300 ( 312 total )

Industry: Medical - Drugs

Record: 281

07/12/2011

Industry Report

Pages: 7

Monthly Rx Highlights - June 2011

Provider: DUNCAN-WILLIAMS, INC.

Analyst: RIVKIND I

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 282

06/29/2011

Company Report

Pages: 14

Surveying Landscape Post-AMS Deal

Provider: DUNCAN-WILLIAMS, INC.

Analyst: RIVKIND I

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 283

06/22/2011

Company Report

Pages: 2

AMS Acquisition

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 284

06/22/2011

Company Report

Pages: 7

Price: 24.95

Industry: Medical - Drugs

Record: 285

05/17/2011

Company Report

Pages: 7

Price: 24.95

Industry: Medical - Drugs

Record: 286

04/29/2011

Company Report

Pages: 15

Still Undervalued But Less Exciting

Provider: DUNCAN-WILLIAMS, INC.

Analyst: RIVKIND I

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 287

04/19/2011

Company Report

Pages: 4

AMS Acquisition - Buy

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 288

04/15/2011

Daily Note

Pages: 21

Previewing the Quarter - 1Q11

Provider: DUNCAN-WILLIAMS, INC.

Analyst: RIVKIND I

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 289

04/14/2011

Daily Note

Pages: 20

Previewing the Quarter - 1Q11

Provider: DUNCAN-WILLIAMS, INC.

Analyst: RIVKIND I

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 290

04/13/2011

Industry Report

Pages: 7

Monthly Rx Highlights - March 2011

Provider: DUNCAN-WILLIAMS, INC.

Analyst: RIVKIND I

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 291

04/13/2011

Company Report

Pages: 7

Price: 24.95

Industry: Medical - Drugs

Record: 292

04/11/2011

Company Report

Pages: 13

Building Urology Scale & Longer Term Value

Provider: DUNCAN-WILLIAMS, INC.

Analyst: RIVKIND I

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 293

03/31/2011

Company Report

Pages: 4

Updating - Estimates Buy

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 294

03/23/2011

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Drugs

Record: 295

03/16/2011

Industry Report

Pages: 7

Monthly Rx Highlights - February 2011

Provider: DUNCAN-WILLIAMS, INC.

Analyst: RIVKIND I

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 296

02/28/2011

Company Report

Pages: 5

Strong Quarter; Raising 2011 Guidance

Provider: DUNCAN-WILLIAMS, INC.

Analyst: RIVKIND I

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 297

02/28/2011

Company Report

Pages: 16

Integration on Track; Deals Pending

Provider: DUNCAN-WILLIAMS, INC.

Analyst: RIVKIND I

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 298

02/16/2011

Industry Report

Pages: 7

Monthly Rx Highlights - January 2011

Provider: DUNCAN-WILLIAMS, INC.

Analyst: RIVKIND I

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 299

01/28/2011

Company Report

Pages: 11

Early Stage Cancer Deal; Value TBD

Provider: DUNCAN-WILLIAMS, INC.

Analyst: RIVKIND I

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Drugs

Record: 300

01/12/2011

Industry Report

Pages: 6

Monthly Rx Highlights - December 2010

Provider: DUNCAN-WILLIAMS, INC.

Analyst: RIVKIND I

Price: 25.00

Research Provided by a Third Party
// eof